• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alkem Laboratories Limited — Updates, 22-09-2025: Press Release

    22-09-2025 | 04:01 pm

    Alkem Laboratories launched Pertuza, a pertuzumab biosimilar, in India for HER2-positive breast cancer. This affordable, indigenously-developed product aims to expand treatment access, strengthening Alkem's oncology portfolio and potentially boosting sales.

    No comments yet. Be the first to comment!

    All announcements from Alkem Laboratories Limited